IFP Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

IFP Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-600	Closed	-$9K	–	3553
2018 Q4	$9K	Buy	+600	New	+$11.4K	﹤0.01%	2576

Other funds holding GRTS

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFP Advisors's GRTS Position: Q1 2019 in Review

IFP Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2019, closing a stake of 600 shares — an estimated $9K sold.

IFP Advisors first reported a position in GRTS in Q4 2018 and held it in 1 quarter. The position peaked at $9K in Q4 2018. 54 funds tracked by Wall St. Rank hold GRTS as of Q1 2019.

IFP Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
IFP Advisors sold 600 Gritstone bio, Inc. Common Stock shares in Q1 2019, an estimated $9K.
IFP Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
IFP Advisors's Gritstone bio, Inc. Common Stock position peaked at $9K in Q4 2018.
54 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.